315 related articles for article (PubMed ID: 32023985)
1. Therapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo Study.
Rego GNA; Nucci MP; Mamani JB; Oliveira FA; Marti LC; Filgueiras IS; Ferreira JM; Real CC; Faria DP; Espinha PL; Fantacini DMC; Souza LEB; Covas DT; Buchpiguel CA; Gamarra LF
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023985
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Evaluation of Hyperthermia Magnetic Technique Indicating the Best Strategy for Internalization of Magnetic Nanoparticles Applied in Glioblastoma Tumor Cells.
Mamani JB; Souza TKF; Nucci MP; Oliveira FA; Nucci LP; Alves AH; Rego GNA; Marti L; Gamarra LF
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452180
[TBL] [Abstract][Full Text] [Related]
4. Magnetic hyperthermia therapy in glioblastoma tumor on-a-Chip model.
Mamani JB; Marinho BS; Rego GNA; Nucci MP; Alvieri F; Santos RSD; Ferreira JVM; Oliveira FA; Gamarra LF
Einstein (Sao Paulo); 2020; 18():eAO4954. PubMed ID: 31939525
[TBL] [Abstract][Full Text] [Related]
5. Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells.
Soleymani M; Khalighfard S; Khodayari S; Khodayari H; Kalhori MR; Hadjighassem MR; Shaterabadi Z; Alizadeh AM
Sci Rep; 2020 Feb; 10(1):1695. PubMed ID: 32015364
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969
[TBL] [Abstract][Full Text] [Related]
7. Thermosensitive/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia.
Zhang ZQ; Song SC
Biomaterials; 2016 Nov; 106():13-23. PubMed ID: 27543919
[TBL] [Abstract][Full Text] [Related]
8. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment.
Silva AC; Oliveira TR; Mamani JB; Malheiros SM; Malavolta L; Pavon LF; Sibov TT; Amaro E; Tannús A; Vidoto EL; Martins MJ; Santos RS; Gamarra LF
Int J Nanomedicine; 2011; 6():591-603. PubMed ID: 21674016
[TBL] [Abstract][Full Text] [Related]
9. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles.
Chauhan A; Midha S; Kumar R; Meena R; Singh P; Jha SK; Kuanr BK
Biomater Sci; 2021 Apr; 9(8):2972-2990. PubMed ID: 33635305
[TBL] [Abstract][Full Text] [Related]
10. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.
Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I
Biomaterials; 2017 Oct; 141():210-222. PubMed ID: 28689117
[TBL] [Abstract][Full Text] [Related]
11. Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma.
Babincová N; Sourivong P; Babinec P; Bergemann C; Babincová M; Durdík Š
Z Naturforsch C J Biosci; 2018 Jul; 73(7-8):265-271. PubMed ID: 29894307
[TBL] [Abstract][Full Text] [Related]
12. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
[TBL] [Abstract][Full Text] [Related]
13. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
Du Y; Liu X; Liang Q; Liang XJ; Tian J
Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
[TBL] [Abstract][Full Text] [Related]
14. Iron Oxide Nanoflowers @ CuS Hybrids for Cancer Tri-Therapy: Interplay of Photothermal Therapy, Magnetic Hyperthermia and Photodynamic Therapy.
Curcio A; Silva AKA; Cabana S; Espinosa A; Baptiste B; Menguy N; Wilhelm C; Abou-Hassan A
Theranostics; 2019; 9(5):1288-1302. PubMed ID: 30867831
[TBL] [Abstract][Full Text] [Related]
15. Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases dissemination.
Garanina AS; Naumenko VA; Nikitin AA; Myrovali E; Petukhova AY; Klimyuk SV; Nalench YA; Ilyasov AR; Vodopyanov SS; Erofeev AS; Gorelkin PV; Angelakeris M; Savchenko AG; Wiedwald U; Majouga Dr AG; Abakumov MA
Nanomedicine; 2020 Apr; 25():102171. PubMed ID: 32084594
[TBL] [Abstract][Full Text] [Related]
16. Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients.
Grauer O; Jaber M; Hess K; Weckesser M; Schwindt W; Maring S; Wölfer J; Stummer W
J Neurooncol; 2019 Jan; 141(1):83-94. PubMed ID: 30506500
[TBL] [Abstract][Full Text] [Related]
17. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.
Mahmoudi K; Bouras A; Bozec D; Ivkov R; Hadjipanayis C
Int J Hyperthermia; 2018 Dec; 34(8):1316-1328. PubMed ID: 29353516
[TBL] [Abstract][Full Text] [Related]
18. Magnetic hyperthermia enhances cell toxicity with respect to exogenous heating.
Sanz B; Calatayud MP; Torres TE; Fanarraga ML; Ibarra MR; Goya GF
Biomaterials; 2017 Jan; 114():62-70. PubMed ID: 27846403
[TBL] [Abstract][Full Text] [Related]
19. Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors.
Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Gazeau F; Guyot F; Chebbi I
J Nanobiotechnology; 2019 Dec; 17(1):126. PubMed ID: 31870376
[TBL] [Abstract][Full Text] [Related]
20. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
